Textbook of Pharmacoepidemiology - download pdf or read online
By Brian L. Strom, Stephen E. Kimmel, Sean Hennessy
ISBN-10: 1118344820
ISBN-13: 9781118344828
ISBN-10: 1118344863
ISBN-13: 9781118344866
Textbook of Pharmacoepidemiology, moment version, offers an
introduction to pharmacoepidemiology and the knowledge resources, methods
and purposes utilized in scientific learn, the pharmaceutical industry
and regulatory agencies.
Drawing upon the 5th version of the authoritative reference,
Pharmacoepidemiology, this re-creation covers the major learning
requirements of the self-discipline. The textbook presents an creation to
pharmacoepidemiology, pharmacoepidemiological facts resources, special
issues in method, unique purposes and destiny advancements in
the box. up to date studying good points reminiscent of case reviews, key issues and
Suggested additional studying are incorporated through the text.
Textbook of Pharmacoepidemiology is a pragmatic academic source for
upper-level undergraduates, graduate scholars, post-doctoral fellows in
schools of public well-being, pharmacy and drugs, and for everybody learning
and operating in pharmacoepidemiology.
Read Online or Download Textbook of Pharmacoepidemiology PDF
Similar pharmacology books
New PDF release: High-Yield Pharmacology (3rd Edition) (High-Yield Series)
Now in its 3rd variation, High-Yield™ Pharmacology presents a succinct overview of pharmacology whereas clarifying tricky thoughts. Need-to-know details is gifted in a transparent, concise define structure. extra beneficial properties contain up-to-date drug references, a drug index, key issues in daring, and tables summarizing key evidence.
Read e-book online In Silico Methods for Predicting Drug Toxicity PDF
This exact quantity explores in silico equipment for pharmaceutical toxicity via combining the theoretical complicated study with the sensible program of the instruments. starting with a piece masking refined versions addressing the binding to receptors, pharmacokinetics and adsorption, metabolism, distribution, and excretion, the e-book maintains with chapters delving into types for particular toxicological and ecotoxicological endpoints, in addition to huge perspectives of the most tasks and new views as a way to most likely enhance our method of modelling prescription drugs.
- Opioid Analgesics
- Pharmacology and Pharmacokinetics
- Pharmacology of the Coronary Circulation. Volume 10
- Angiogenesis: From the Molecular to Integrative Pharmacology
- The hands-on guide to clinical pharmacology
Additional info for Textbook of Pharmacoepidemiology
Example text
It is clear that the exploration of the costs of drug use requires consideration of more than just the costs of the drugs themselves. The costs of a drug’s adverse effects may be substantially higher than the cost of the drug itself, if these adverse effects result in additional medical care and possibly even hospitalizations. Conversely, a drug’s beneficial effects could reduce the need for medical care, resulting in savings that can be much larger than the cost of the drug itself. As with studies of drug utilization, the economic implications of drug use can be predicted prior to marketing, but can only be rigorously studied after marketing (see Chapter 17).
These effects were not detected prior to marketing, as patients with underlying cardiovascular or respiratory disease were excluded from the premarketing studies. Finally, to obtain approval to market a drug, a manufacturer needs to evaluate its overall safety and efficacy, but does not need to evaluate its safety and efficacy relative to any other drugs available for the same indication. To the contrary, with the exception of illnesses that could not ethically be treated with placebos, such as serious infections and malignancies, it is generally considered preferable, or even mandatory, to have studies with placebo controls.
The quantitative strength of an association refers to the effect size. To evaluate this, one asks whether the magnitude of the observed difference between the two study groups is large. A quantitatively large association can only be created by a causal association or a large error, which should be apparent in evaluating the methods of a study. A quantitatively small association may still be causal, but it could be created by a subtle error, which would not be apparent in evaluating the study. 0 a weak association.
Textbook of Pharmacoepidemiology by Brian L. Strom, Stephen E. Kimmel, Sean Hennessy
by Mark
4.2